Stock Analysis on Net
Stock Analysis on Net

Bristol-Myers Squibb Co. (NYSE:BMY)

株価純利益率 (P/E) 
2005年以降

Microsoft Excel

計算

Bristol-Myers Squibb Co.、 P/E、長期トレンド計算

Microsoft Excel
P/E = 株価1, 2, 3 ÷ 1株当たり利益1 (EPS) EPS1 = BMSに帰属する当期純利益(損失)1
(数百万単位)		 ÷ 発行済普通株式数2
2024/02/13 12.27 = 48.71 ÷ 3.97 3.97 = 8,025 ÷ 2,022,193,411
2023/02/14 23.97 = 72.25 ÷ 3.01 3.01 = 6,327 ÷ 2,098,775,978
2022/02/09 20.92 = 67.14 ÷ 3.21 3.21 = 6,994 ÷ 2,179,712,820
2021/02/10 — = 60.00 ÷ -4.02 -4.02 = -9,015 ÷ 2,240,475,153
2020/02/24 41.99 = 63.97 ÷ 1.52 1.52 = 3,439 ÷ 2,257,510,796
2019/02/25 16.81 = 50.65 ÷ 3.01 3.01 = 4,920 ÷ 1,632,675,877
2018/02/13 103.55 = 63.87 ÷ 0.62 0.62 = 1,007 ÷ 1,632,582,502
2017/02/21 20.56 = 54.78 ÷ 2.66 2.66 = 4,457 ÷ 1,672,715,340
2016/02/12 64.22 = 60.20 ÷ 0.94 0.94 = 1,565 ÷ 1,669,459,090
2015/02/13 49.80 = 60.04 ÷ 1.21 1.21 = 2,004 ÷ 1,662,118,446
2014/02/14 35.01 = 54.37 ÷ 1.55 1.55 = 2,563 ÷ 1,650,232,566
2013/02/15 30.56 = 36.58 ÷ 1.20 1.20 = 1,960 ÷ 1,637,354,662
2012/02/17 15.07 = 33.12 ÷ 2.20 2.20 = 3,709 ÷ 1,688,107,071
2011/02/18 13.99 = 25.49 ÷ 1.82 1.82 = 3,102 ÷ 1,702,427,438
2010/02/19 4.03 = 24.95 ÷ 6.19 6.19 = 10,612 ÷ 1,714,140,539
2009/02/20 7.68 = 20.37 ÷ 2.65 2.65 = 5,247 ÷ 1,979,509,306
2008/02/22 20.60 = 22.53 ÷ 1.09 1.09 = 2,165 ÷ 1,979,387,706
2007/02/26 34.64 = 27.19 ÷ 0.78 0.78 = 1,585 ÷ 2,019,481,440
2006/03/14 14.96 = 22.91 ÷ 1.53 1.53 = 3,000 ÷ 1,959,073,035

レポートに基づく: 10-K (報告日: 2023-12-31), 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31), 10-K (報告日: 2017-12-31), 10-K (報告日: 2016-12-31), 10-K (報告日: 2015-12-31), 10-K (報告日: 2014-12-31), 10-K (報告日: 2013-12-31), 10-K (報告日: 2012-12-31), 10-K (報告日: 2011-12-31), 10-K (報告日: 2010-12-31), 10-K (報告日: 2009-12-31), 10-K (報告日: 2008-12-31), 10-K (報告日: 2007-12-31), 10-K (報告日: 2006-12-31), 10-K (報告日: 2005-12-31).

1 米ドル

2 分割と株式配当の調整済みデータ。

3 Bristol-Myers Squibb Co.アニュアルレポート提出日時点の終値

競合他社との比較

Bristol-Myers Squibb Co.、 P/E、長期トレンド、競合他社との比較

Microsoft Excel
Bristol-Myers Squibb Co. AbbVie Inc. Amgen Inc. Danaher Corp. Eli Lilly & Co. Gilead Sciences Inc. Johnson & Johnson Merck & Co. Inc. Moderna Inc. Pfizer Inc. Regeneron Pharmaceuticals Inc. Thermo Fisher Scientific Inc.
2024/02/13 12.27 63.84 23.14 39.09 135.24 16.17 10.73 893.99 — 73.42 25.99 35.65
2023/02/14 23.97 22.62 19.56 25.65 50.08 22.68 22.97 19.21 6.43 7.58 19.68 30.55
2022/02/09 20.92 22.07 21.05 29.94 40.66 12.36 20.93 14.78 5.00 11.76 8.37 27.35
2021/02/10 — 40.17 18.82 44.49 31.95 641.48 28.92 26.72 — 19.62 15.09 27.89
2020/02/24 41.99 17.82 17.07 38.34 16.19 16.45 25.99 20.60 — 11.63 19.86 33.36
2019/02/25 16.81 20.60 14.01 29.77 39.13 15.26 23.74 33.46 — 21.58 18.17 35.19
2018/02/13 103.55 35.47 64.06 27.25 — 22.75 268.10 61.63 — 9.99 28.99 37.66
2017/02/21 20.56 16.54 16.03 23.02 32.39 6.83 20.08 46.14 — 28.10 42.64 30.45
2016/02/12 64.22 17.01 15.95 17.85 33.35 6.75 18.80 31.64 — 26.37 60.50 26.19
2015/02/13 49.80 55.08 22.96 23.69 33.06 12.85 17.15 13.94 — 23.03 118.44 27.26
2014/02/14 35.01 19.64 18.69 19.74 13.88 42.00 18.72 37.83 — 9.32 77.00 38.43
2013/02/15 30.56 11.51 15.68 17.73 14.99 25.20 19.64 20.94 — 13.51 21.42 22.54
2012/02/17 15.07 — 14.61 16.92 10.42 12.20 18.48 18.63 — 15.99 — 15.58
2011/02/18 13.99 — 10.53 18.29 7.86 10.68 12.23 116.63 — 18.63 — 20.87
2010/02/19 4.03 — 12.10 20.93 9.18 16.29 14.22 9.00 — 16.41 — 23.49
2009/02/20 7.68 — 12.06 12.56 — 20.29 11.67 6.53 — 10.25 — 15.25
2008/02/22 20.60 — 15.64 17.35 19.26 25.19 17.07 29.88 — 18.51 — 30.76
2007/02/26 34.64 — 25.43 19.65 22.40 — 17.02 21.57 — 9.18 — 113.28
2006/03/14 14.96 — 23.70 21.38 31.90 34.15 16.95 16.62 — 23.92 — 25.36

レポートに基づく: 10-K (報告日: 2023-12-31), 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31), 10-K (報告日: 2017-12-31), 10-K (報告日: 2016-12-31), 10-K (報告日: 2015-12-31), 10-K (報告日: 2014-12-31), 10-K (報告日: 2013-12-31), 10-K (報告日: 2012-12-31), 10-K (報告日: 2011-12-31), 10-K (報告日: 2010-12-31), 10-K (報告日: 2009-12-31), 10-K (報告日: 2008-12-31), 10-K (報告日: 2007-12-31), 10-K (報告日: 2006-12-31), 10-K (報告日: 2005-12-31).

産業部門との比較: 製薬、バイオテクノロジー、ライフサイエンス

Bristol-Myers Squibb Co.、 P/E、長期トレンド、産業部門との比較: 製薬、バイオテクノロジー、ライフサイエンス

Microsoft Excel
Bristol-Myers Squibb Co. 製薬、バイオテクノロジー、ライフサイエンス
2024/02/13 12.27 35.36
2023/02/14 23.97 19.24
2022/02/09 20.92 17.76
2021/02/10 — 37.29
2020/02/24 41.99 20.82
2019/02/25 16.81 23.13
2018/02/13 103.55 34.49
2017/02/21 20.56 20.28
2016/02/12 64.22 18.89
2015/02/13 49.80 20.74
2014/02/14 35.01 19.10
2013/02/15 30.56 17.34
2012/02/17 15.07 16.25
2011/02/18 13.99 15.61
2010/02/19 4.03 11.39
2009/02/20 7.68 11.95
2008/02/22 20.60 19.74
2007/02/26 34.64 17.28
2006/03/14 14.96 20.69

レポートに基づく: 10-K (報告日: 2023-12-31), 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31), 10-K (報告日: 2017-12-31), 10-K (報告日: 2016-12-31), 10-K (報告日: 2015-12-31), 10-K (報告日: 2014-12-31), 10-K (報告日: 2013-12-31), 10-K (報告日: 2012-12-31), 10-K (報告日: 2011-12-31), 10-K (報告日: 2010-12-31), 10-K (報告日: 2009-12-31), 10-K (報告日: 2008-12-31), 10-K (報告日: 2007-12-31), 10-K (報告日: 2006-12-31), 10-K (報告日: 2005-12-31).

業界との比較: 医療

Bristol-Myers Squibb Co.、 P/E、長期トレンド、業界との比較: 医療

Microsoft Excel
Bristol-Myers Squibb Co. 医療
2024/02/13 12.27 30.09
2023/02/14 23.97 314,676.00
2022/02/09 20.92 19.87
2021/02/10 — 29.50
2020/02/24 41.99 21.10
2019/02/25 16.81 25.51
2018/02/13 103.55 29.68
2017/02/21 20.56 21.38
2016/02/12 64.22 19.10
2015/02/13 49.80 20.89
2014/02/14 35.01 18.14
2013/02/15 30.56 15.43
2012/02/17 15.07 15.48
2011/02/18 13.99 14.45
2010/02/19 4.03 11.43
2009/02/20 7.68 12.78
2008/02/22 20.60 18.99
2007/02/26 34.64 18.38
2006/03/14 14.96 21.11

レポートに基づく: 10-K (報告日: 2023-12-31), 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31), 10-K (報告日: 2017-12-31), 10-K (報告日: 2016-12-31), 10-K (報告日: 2015-12-31), 10-K (報告日: 2014-12-31), 10-K (報告日: 2013-12-31), 10-K (報告日: 2012-12-31), 10-K (報告日: 2011-12-31), 10-K (報告日: 2010-12-31), 10-K (報告日: 2009-12-31), 10-K (報告日: 2008-12-31), 10-K (報告日: 2007-12-31), 10-K (報告日: 2006-12-31), 10-K (報告日: 2005-12-31).